As the public becomes more aware of the controversy surrounding the anti-nausea drug Zofran and its potential to cause birth defects when taken by pregnant women, lawsuits against the manufacturer GlaxoSmithKline (GSK) have been flooding in. Now joining plaintiffs from several other states is a family from Alabama, alleging that Zofran caused severe developmental defects … Read more…
Zofran, GlaxoSmithKline’s anti-nausea drug, has been associated with serious birth defects in babies when used during the first trimester of pregnancy to treat morning sickness. Lawsuits against the company continue to pile up – on April 17, a Massachusetts woman joined the fight against the pharmaceutical company after she was forced to terminate a pregnancy … Read more…
GlaxoSmithKline is facing a number of lawsuits related to the anti-nausea drug Zofran and its purported effects on unborn children. Many of these lawsuits assert that the pharmaceutical enterprise was fully aware that prescribing Zofran to pregnant women could result in birth defects, and yet did nothing to prevent it. A lawsuit by plaintiff Cheri … Read more…
